{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:02:08Z","timestamp":1789549328368,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Res."],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune-mediated alloimmunization and hemolytic anemia can complicate ABO-incompatible hematopoietic stem cell transplantation (HSCT). After major ABO-incompatible HSCT, clinical manifestations may include pure red cell aplasia and delayed hemolysis. Passenger lymphocyte syndrome and delayed hemolysis are typical complications of minor ABO-incompatible HSCT. Because delayed hemolysis after major\u00a0or minor ABO mismatch may be indistinguishable, the terms host-associated alloimmune hemolytic anemia and graft-associated alloimmune hemolytic anemia have been tentatively proposed to distinguish these conditions according to their host or graft origin. However, the rarity of these subgroups may limit the clinical utility of this classification. Management across the clinical spectrum includes transfusion support, plasmapheresis, and therapeutics related to immunomodulatory therapies.<\/jats:p>","DOI":"10.1007\/s44313-026-00173-y","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:24:13Z","timestamp":1789539853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the spectrum of post-HSCT hemolysis: from passenger lymphocyte syndrome to host- and graft-associated alloimmune hemolytic anemia"],"prefix":"10.1007","volume":"61","author":[{"given":"Dong Wook","family":"Jekarl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungjun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay Ho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"17","key":"173_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA. Hematopoietic stem cell transplantation. N Engl J Med. 2006;354(17):1813\u201326.","journal-title":"N Engl J Med"},{"issue":"8","key":"173_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41571-020-0356-4","volume":"17","author":"BR Blazar","year":"2020","unstructured":"Blazar BR, Hill GR, Murphy WJ. Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD. Nat Rev Clin Oncol. 2020;17(8):475\u201392.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"173_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13287-024-04126-z","volume":"16","author":"AA Aljagthmi","year":"2025","unstructured":"Aljagthmi AA, Abdel-Aziz AK. Hematopoietic stem cells: understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation. Stem Cell Res Ther. 2025;16(1):60\u201371.","journal-title":"Stem Cell Res Ther"},{"key":"173_CR4","first-page":"13","volume":"7","author":"The Korean Society of Blood and Marrow Transplantation","year":"2025","unstructured":"The Korean Society of Blood and Marrow Transplantation. Newsletter. 2025;7:13\u20135.","journal-title":"Newsletter"},{"issue":"4","key":"173_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5045\/br.2022.2022194","volume":"57","author":"DH Kim","year":"2022","unstructured":"Kim DH, Seo J, Shin D, et al. Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis. Blood Res. 2022;57(4):264\u201371.","journal-title":"Blood Res"},{"issue":"6","key":"173_CR6","doi-asserted-by":"publisher","first-page":"483.e1","DOI":"10.1016\/j.jtct.2021.02.031","volume":"27","author":"BL Scott","year":"2021","unstructured":"Scott BL, Pasquini MC, Fei M, et al. Myeloablative versus reduced-intensity conditioning for hematopoietic cell transplantation in acute myelogenous leukemia and myelodysplastic syndromes-long-term follow-up of the BMT CTN 0901 Clinical Trial. Transplant Cell Ther. 2021;27(6):483.e1-483.e6.","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"173_CR7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/ajh.26320","volume":"96","author":"BS Cho","year":"2021","unstructured":"Cho BS, Min GJ, Park SS, et al. Low-dose thymoglobulin for prevention of chronic graft-versus-host disease in transplantation from an HLA-matched sibling donor. Am J Hematol. 2021;96(11):1441\u20139.","journal-title":"Am J Hematol"},{"issue":"3","key":"173_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2014-02-514745","volume":"124","author":"KA Markey","year":"2014","unstructured":"Markey KA, MacDonald KP, Hill GR. The biology of graft-versus-host disease: experimental systems instructing clinical practice. Blood. 2014;124(3):354\u201362.","journal-title":"Blood"},{"issue":"9","key":"173_CR9","doi-asserted-by":"publisher","first-page":"907.e1","DOI":"10.1016\/j.jtct.2024.06.023","volume":"30","author":"J Kanda","year":"2024","unstructured":"Kanda J, Mitsuyoshi T, Sakurai M, et al. Real-world outcomes of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in Japan: retrospective analysis of the Transplant Registry Unified Management Program Registry. Transplant Cell Ther. 2024;30(9):907.e1-907.e16.","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"173_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5045\/kjh.2011.46.2.80","volume":"46","author":"CK Min","year":"2011","unstructured":"Min CK. The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma. Korean J Hematol. 2011;46(2):80\u20137.","journal-title":"Korean J Hematol"},{"issue":"1","key":"173_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbmt.2018.08.004","volume":"25","author":"SS Park","year":"2019","unstructured":"Park SS, Jeon YW, Min GJ, et al. Graft-versus-host disease-free, relapse-free survival after allogeneic stem cell transplantation for myelodysplastic syndrome. Biol Blood Marrow Transplant. 2019;25(1):63\u201372.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"173_CR12","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","volume":"110","author":"SJ Lee","year":"2007","unstructured":"Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576\u201383.","journal-title":"Blood"},{"issue":"2","key":"173_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","volume":"127","author":"C Kollman","year":"2016","unstructured":"Kollman C, Spellman SR, Zhang M, et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. 2016;127(2):260\u20137.","journal-title":"Blood"},{"issue":"10","key":"173_CR14","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1038\/s41375-025-02685-5","volume":"39","author":"E Rettinger","year":"2025","unstructured":"Rettinger E, Heckl D, Gibson B, et al. The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia. Leukemia. 2025;39(10):2313\u201328.","journal-title":"Leukemia"},{"issue":"3","key":"173_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/tan.14167","volume":"97","author":"DW Jekarl","year":"2021","unstructured":"Jekarl DW, Lee GD, Yoo JB, et al. HLA-A, -B, -C, -DRB1 allele and haplotype frequencies of the Korean population and performance characteristics of HLA typing by next-generation sequencing. HLA. 2021;97(3):188\u201397.","journal-title":"HLA"},{"key":"173_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3343\/alm.2025.0393","volume":"46","author":"H Lee","year":"2026","unstructured":"Lee H, Lee GD, Jekarl DW, Kim M, Kim Y. High-resolution eight-digit human leukocyte antigen-A, -B, -C, and -DRB1 allele and haplotype frequencies in South Koreans using next-generation sequencing. Ann Lab Med. 2026;46:465\u201375.","journal-title":"Ann Lab Med"},{"issue":"8","key":"173_CR17","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bbmt.2013.03.018","volume":"19","author":"SB Garrett","year":"2013","unstructured":"Garrett SB, Gehrie EA, Bolan CD, Savani BN. Clinical guide to ABO-incompatible allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(8):1152\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 1","key":"173_CR18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.5045\/br.2023.2023004","volume":"58","author":"DW Jekarl","year":"2023","unstructured":"Jekarl DW, Kim JK, Han JH, et al. Transfusion support in hematopoietic stem cell transplantation. Blood Res. 2023;58(Suppl 1):S1\u20137.","journal-title":"Blood Res"},{"issue":"9","key":"173_CR19","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41409-022-01737-z","volume":"57","author":"B Lemaire","year":"2022","unstructured":"Lemaire B, Combescure C, Chalandon Y, Vuilleumier N, Abramowski SW. Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation. Bone Marrow Transplant. 2022;57(9):1405\u201310.","journal-title":"Bone Marrow Transplant"},{"key":"173_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1182\/asheducation-2015.1.378","volume":"2015","author":"A Holbro","year":"2015","unstructured":"Holbro A, Passweg JR. Management of hemolytic anemia following allogeneic stem cell transplantation. Hematology Am Soc Hematol Educ Program. 2015;2015:378\u201384.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"173_CR21","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1182\/bloodadvances.2021006279","volume":"6","author":"Y Migdady","year":"2022","unstructured":"Migdady Y, Pang Y, Kalsi SS, Childs R, Arai S. Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics. Blood Adv. 2022;6(8):2707\u201321.","journal-title":"Blood Adv"},{"issue":"9","key":"173_CR22","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/bmt.2011.135","volume":"46","author":"SD Rowley","year":"2011","unstructured":"Rowley SD, Donato ML, Bhattacharyya P. Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2011;46(9):1167\u201385.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"173_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.transci.2004.01.013","volume":"31","author":"N Contentin","year":"2004","unstructured":"Contentin N, Lenain P, Chamouni P, et al. Transient anti rhesus alloantibody produced by graft after non-myeloablative allogeneic stem cell transplant. Transfus Apher Sci. 2004;31(3):191\u20137.","journal-title":"Transfus Apher Sci"},{"issue":"10","key":"173_CR24","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1111\/trf.14232","volume":"57","author":"R Bailen","year":"2017","unstructured":"Bailen R, Kwon M, Perez-Corral AM, et al. Transient hemolysis due to anti-D and anti-A1 produced by engrafted donor\u2019s lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation. Transfusion. 2017;57(10):2355\u20138.","journal-title":"Transfusion"},{"issue":"2","key":"173_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/jha2.190","volume":"2","author":"JS Hecker","year":"2021","unstructured":"Hecker JS, Wahida A, Hameister E, Filo A, Ruland J, et al. ABO subgroup incompatibility with severe hemolysis after consecutive allogeneic stem cell transplantations. eJHaem. 2021;2(2):280\u20134.","journal-title":"eJHaem"},{"issue":"3","key":"173_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1537-2995.1998.38398222868.x","volume":"38","author":"A Lopez","year":"1998","unstructured":"Lopez A, de la Rubia J, Arriaga F, et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion. 1998;38(3):247\u201351.","journal-title":"Transfusion"},{"issue":"2","key":"173_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1046\/j.1537-2995.2003.00303.x","volume":"43","author":"N Izumi","year":"2003","unstructured":"Izumi N, Fuse I, Furukawa T, et al. Long-term production of pre-existing alloantibodies to E and c after allogenic BMT in a patient with aplastic anemia resulting in delayed hemolytic anemia. Transfusion. 2003;43(2):241\u20135.","journal-title":"Transfusion"},{"issue":"4","key":"173_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/pbc.21187","volume":"50","author":"MM Chao","year":"2008","unstructured":"Chao MM, Levine JE, Ferrara JL, et al. Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H. Pediatr Blood Cancer. 2008;50(4):917\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"173_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/trf.12815","volume":"55","author":"S Hosoba","year":"2015","unstructured":"Hosoba S, Jaye DL, Cohen C, Roback JD, Waller EK. Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature. Transfusion. 2015;55(2):259\u201364.","journal-title":"Transfusion"},{"issue":"4","key":"173_CR30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1080\/10428194.2017.1352095","volume":"59","author":"M Isobe","year":"2018","unstructured":"Isobe M, Konuma T, Abe-Wada Y, et al. Alloimmune hemolysis due to major RhE incompatibility after unrelated cord blood transplantation. Leuk Lymphoma. 2018;59(4):1000\u20133.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"173_CR31","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/bmt.2014.309","volume":"50","author":"K Patrick","year":"2015","unstructured":"Patrick K, Lau W, Gassas A, et al. Major ABO incompatible BMT in children: determining what residual volume of donor red cells can safely be infused following red cell depletion. Bone Marrow Transplant. 2015;50(4):536\u20139.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"173_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/bmt.2015.230","volume":"51","author":"RS Nickel","year":"2016","unstructured":"Nickel RS, Waller EK, Qayed M, Chiang KY. Clinically significant adverse events after major ABO mismatch BMT. Bone Marrow Transplant. 2016;51(1):148\u20139.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"173_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/bjh.12210","volume":"160","author":"FM Aung","year":"2013","unstructured":"Aung FM, Lichtiger B, Bassett R, et al. Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. Br J Haematol. 2013;160(6):798\u2013805.","journal-title":"Br J Haematol"},{"issue":"4","key":"173_CR34","doi-asserted-by":"publisher","first-page":"431.e1","DOI":"10.1016\/j.jtct.2026.01.003","volume":"32","author":"Y Kiyoki","year":"2026","unstructured":"Kiyoki Y, Maruyama Y, Maruyama Y, et al. Tracking of donor erythropoiesis following ABO-incompatible allogeneic hematopoietic stem cell transplantion. Transplant Cell Ther. 2026;32(4):431.e1-431.e4.","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"173_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/trf.17743","volume":"64","author":"J Cao","year":"2024","unstructured":"Cao J, Lu S, Luo D, et al. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab. Transfusion. 2024;64(3):510\u20136.","journal-title":"Transfusion"},{"issue":"3","key":"173_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tmrv.2020.06.004","volume":"34","author":"MM Moosavi","year":"2020","unstructured":"Moosavi MM, Duncan A, Stowell SR, Roback JD, Sullivan HC. Passenger lymphocyte syndrome; a review of the diagnosis, treatment, and proposed detection protocol. Transfus Med Rev. 2020;34(3):178\u201387.","journal-title":"Transfus Med Rev"},{"issue":"5","key":"173_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF00321102","volume":"53","author":"RJ Haas","year":"1986","unstructured":"Haas RJ, Rieber P, Helmig M, Strobel E, Belohradsky BH. Acquired immune haemolysis by anti A1 antibody following bone marrow transplantation. Blut. 1986;53(5):401\u20134.","journal-title":"Blut"},{"issue":"1","key":"173_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1182\/blood.V67.1.177.177","volume":"67","author":"J Hows","year":"1986","unstructured":"Hows J, Beddow K, Gordon-Smith E, Branch DR, Spruce W, Sniecinski I. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood. 1986;67(1):177\u201381.","journal-title":"Blood"},{"issue":"11","key":"173_CR39","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1182\/blood.V79.11.3076.bloodjournal79113076","volume":"79","author":"JL Gajewski","year":"1992","unstructured":"Gajewski JL, Petz LD, Calhoun L, et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood. 1992;79(11):3076\u201385.","journal-title":"Blood"},{"issue":"2","key":"173_CR40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1182\/blood.V87.2.843.bloodjournal872843","volume":"87","author":"A Toren","year":"1996","unstructured":"Toren A, Dacosta Y, Manny N, Varadi G, Or R, Nagler A. Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation. Blood. 1996;87(2):843\u20134.","journal-title":"Blood"},{"issue":"1","key":"173_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1537-2995.1996.36196190519.x","volume":"36","author":"EW Greeno","year":"1996","unstructured":"Greeno EW, Perry EH, Ilstrup SJ, Weisdorf DJ. Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. Transfusion. 1996;36(1):71\u20134.","journal-title":"Transfusion"},{"issue":"3","key":"173_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/sj.bmt.1700641","volume":"19","author":"M Bornh\u00e4user","year":"1997","unstructured":"Bornh\u00e4user M, Ordemann R, Paaz U, et al. Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysis. Bone Marrow Transplant. 1997;19(3):295\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"173_CR43","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.bmt.1700794","volume":"19","author":"S Oziel-Taieb","year":"1997","unstructured":"Oziel-Taieb S, Faucher-Barbey C, Chabannon C, et al. Early and fatal immune haemolysis after so-called \u201cminor\u201d ABO-incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplant. 1997;19(11):1155\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"173_CR44","first-page":"150","volume":"34","author":"R Moog","year":"1997","unstructured":"Moog R, Melder C, Prumbaum M, Muller N, Schaefer UW. Rapid donor type isoagglutinin production after allogeneic peripheral progenitor cell transplantation. Beitr Infusionsther Transfusionsmed. 1997;34:150\u20132.","journal-title":"Beitr Infusionsther Transfusionsmed"},{"issue":"3","key":"173_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00282-997-0159-4","volume":"39","author":"FM Laurencet","year":"1997","unstructured":"Laurencet FM, Samii K, Bressoud A, Tajeddin M, Easton J, Stelling MJ, et al. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility. Hematol Cell Ther. 1997;39(3):159\u201362.","journal-title":"Hematol Cell Ther"},{"issue":"10","key":"173_CR46","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/sj.bmt.1701226","volume":"21","author":"M Franchini","year":"1998","unstructured":"Franchini M, de Gironcoli M, Gandini G, Vassanelli A, Rocca P, Benedetti F, et al. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT. Bone Marrow Transplant. 1998;21(10):1071\u20133.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"173_CR47","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1046\/j.1537-2995.1999.39080824.x","volume":"39","author":"JP Salmon","year":"1999","unstructured":"Salmon JP, Michaux S, Hermanne JP, Baudoux E, Gerard C, Sontag-Thull D. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion. 1999;39(8):824\u20137.","journal-title":"Transfusion"},{"issue":"6","key":"173_CR48","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1046\/j.1537-2995.2000.40060632.x","volume":"40","author":"A Leo","year":"2000","unstructured":"Leo A, Mytilineos J, Voso MT, et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jka after allogeneic PBPC transplantation. Transfusion. 2000;40(6):632\u20136.","journal-title":"Transfusion"},{"issue":"6","key":"173_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1046\/j.1365-3148.2001.00334.x","volume":"11","author":"CW Tiplady","year":"2001","unstructured":"Tiplady CW, Fitzgerald JM, Jackson GH, Conn JS, Proctor SJ. Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant. Transfus Med. 2001;11(6):455\u20138.","journal-title":"Transfus Med"},{"issue":"12","key":"173_CR50","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/sj.bmt.1703074","volume":"27","author":"PP Young","year":"2001","unstructured":"Young PP, Goodnough LT, Westervelt P, Diersio JF. Immune hemolysis involving non-ABO\/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27(12):1305\u201310.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"173_CR51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1046\/j.1365-2141.2001.02587.x","volume":"112","author":"CD Bolan","year":"2001","unstructured":"Bolan CD, Childs RW, Procter JL, Barrett AJ, Leitman SF. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol. 2001;112(3):787\u201395.","journal-title":"Br J Haematol"},{"issue":"2","key":"173_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/mpo.1295","volume":"38","author":"W Hoegler","year":"2002","unstructured":"Hoegler W, Nachbaur D, Kropshofer G, Wehl G, Schoenitzer D, Nussbaumer W. Abrupt onset of severe passenger lymphocyte syndrome after HLA-mismatched unrelated bone marrow transplantation in a seven-year-old boy. Med Pediatr Oncol. 2002;38(2):143\u20134.","journal-title":"Med Pediatr Oncol"},{"issue":"10","key":"173_CR53","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1046\/j.1537-2995.2002.00209.x","volume":"42","author":"N Worel","year":"2002","unstructured":"Worel N, Greinix HT, Keil F, et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion. 2002;42(10):1293\u2013301.","journal-title":"Transfusion"},{"issue":"2","key":"173_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/1042819021000030036","volume":"44","author":"K Noborio","year":"2003","unstructured":"Noborio K, Muroi K, Izumi T, et al. Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility. Leuk Lymphoma. 2003;44(2):357\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"173_CR55","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.5858\/2003-127-1366-SHDTPL","volume":"127","author":"M Reed","year":"2003","unstructured":"Reed M, Yearsley M, Krugh D, Kennedy MS. Severe hemolysis due to passenger lymphocyte syndrome after hematopoietic stem cell transplantation from an HLA-matched related donor. Arch Pathol Lab Med. 2003;127(10):1366\u20138.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"173_CR56","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2257.2005.00690.x","volume":"27","author":"NJ Curtin","year":"2025","unstructured":"Curtin NJ, Schwarer AP. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility. Clin Lab Haematol. 2025;27(3):206\u20138.","journal-title":"Clin Lab Haematol"},{"issue":"12","key":"173_CR57","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/sj.bmt.1705188","volume":"36","author":"DM Benson","year":"2005","unstructured":"Benson DM, O\u2019Donnell L, Krugh D, et al. Successful management of sudden, massive immune hemolysis following ABO-incompatible allogeneic PBSCT despite methotrexate GvHD prophylaxis. Bone Marrow Transplant. 2005;36(12):1111\u20132.","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"173_CR58","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.bmt.1705674","volume":"39","author":"V Nair","year":"2007","unstructured":"Nair V, Sharma A, Ratheesh J, et al. Severe intravascular haemolysis following minor group mismatched peripheral blood stem cell transplantation. Bone Marrow Transplant. 2007;39(12):805\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"173_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/bmt.2008.79","volume":"42","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Gulbis A, De Padua Silva L, et al. Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT. Bone Marrow Transplant. 2008;42(1):67\u20139.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"173_CR60","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/bmt.2009.202","volume":"45","author":"BR Adams","year":"2010","unstructured":"Adams BR, Miller AN, Costa LJ. Self-limited hemolysis due to anti-D passenger lymphocyte syndrome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45(4):772\u20133.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"173_CR61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.transci.2012.06.027","volume":"47","author":"S Iwanaga","year":"2012","unstructured":"Iwanaga S, Sakaguchi T, Nakanishi K, Furukuwa M, Ishizeki K, Kogawa K. Passenger lymphocyte syndrome with hemophagocytic syndrome after peripheral blood stem-cell transplantation from an HLA-matched full biological sibling: case report. Transfus Apher Sci. 2012;47(3):355\u20138.","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"173_CR62","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12185-013-1360-6","volume":"98","author":"Y Zaimoku","year":"2013","unstructured":"Zaimoku Y, Takami A, Sato H, Utsumi M, Nakao S. IgM anti-recipient ABO antibodies predict acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2013;98(1):96\u2013101.","journal-title":"Int J Hematol"},{"issue":"1","key":"173_CR63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.transci.2012.07.006","volume":"48","author":"CA Akkok","year":"2013","unstructured":"Akkok CA, Haugaa H, Galgerud A, Brinch L. Severe hemolytic transfusion reaction due to anti-A1 following allogeneic stem cell transplantation with minor ABO incompatibility. Transfus Apher Sci. 2013;48(1):63\u20136.","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"173_CR64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000357985","volume":"41","author":"JE Squires","year":"2014","unstructured":"Squires JE. Passenger lymphocyte syndrome: a case report involving non-ABO antibodies. Transfus Med Hemother. 2014;41(2):153\u20135.","journal-title":"Transfus Med Hemother"},{"issue":"3","key":"173_CR65","doi-asserted-by":"publisher","first-page":"191","DOI":"10.46701\/APJBG.2018032018122","volume":"2","author":"Z Xu","year":"2018","unstructured":"Xu Z, Li X, Liu K, et al. Passenger lymphocyte syndrome after minor ABO-incompatible stem cell transplantation: a case report. Blood Genomics. 2018;2(3):191\u20133.","journal-title":"Blood Genomics"},{"issue":"1","key":"173_CR66","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/16078454.2021.1986654","volume":"26","author":"H Teshigawara-Tanabe","year":"2021","unstructured":"Teshigawara-Tanabe H, Hagihara M, Matsumura A, et al. Passenger lymphocyte syndrome after ABO-incompatible allogeneic hematopoietic stem cell transplantation; dynamics of ABO allo-antibody and blood type conversion. Hematology (United States). 2021;26(1):835\u20139.","journal-title":"Hematology (United States)"},{"key":"173_CR67","doi-asserted-by":"publisher","first-page":"1690489","DOI":"10.1155\/2022\/1690489","volume":"2022","author":"DF Noubouossie","year":"2022","unstructured":"Noubouossie DF, Zaanona MIA, Costa LJ, Pham HP, Marques MB, Di Stasi A. Passenger lymphocyte syndrome and autoimmune hypothyroidism following hematopoietic stem cell transplantation. Case Reports Immunol. 2022;2022:1690489.","journal-title":"Case Reports Immunol"},{"key":"173_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02017","volume":"11","author":"NP Buxbaum","year":"2020","unstructured":"Buxbaum NP, Pavletic SZ. Autoimmunity following allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11:2017.","journal-title":"Front Immunol"},{"issue":"2","key":"173_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5045\/br.2017.52.2.119","volume":"52","author":"S Hwang-Bo","year":"2017","unstructured":"Hwang-Bo S, Kim S, Lee JW, et al. Treatment and response of autoimmune cytopenia occurring after allogeneic hematopoietic cell transplantation in children. Blood Res. 2017;52(2):119\u201324.","journal-title":"Blood Res"},{"issue":"1","key":"173_CR70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbmt.2014.09.009","volume":"21","author":"M Wang","year":"2015","unstructured":"Wang M, Wang W, Abeywardane A, et al. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King\u2019s College Hospital. Biol Blood Marrow Transplant. 2015;21(1):60\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"173_CR71","doi-asserted-by":"crossref","unstructured":"Gabelli M, Ademokun C, Cooper N, Amrolia PI. Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anemia in the post-transplant setting. British J Haematol. 2022;196(1):45\u201362.","DOI":"10.1111\/bjh.17648"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-026-00173-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44313-026-00173-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-026-00173-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:02:37Z","timestamp":1789545757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44313-026-00173-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["173"],"URL":"https:\/\/doi.org\/10.1007\/s44313-026-00173-y","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"56"}}